Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

BMI Is Only the Beginning: Accounting for Comorbidity Burden and Patient Heterogeneity

BMI Is Only the Beginning: Accounting for Comorbidity Burden and Patient Heterogeneity Obesity Surgery https://doi.org/10.1007/s11695-025-08039-5 EDITORIAL BMI Is Only the Beginning: Accounting for Comorbidity Burden and Patient Heterogeneity 1 1 Yuan Cheng  · Bin Wei Received: 24 June 2025 / Revised: 25 June 2025 / Accepted: 30 June 2025 © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2025 Dear Editor, incorporate key postoperative endpoints such as T2D remis- sion, magnitude of weight loss, reduction in medication use, We read with great interest the study by Roser et al., titled or improvements in quality of life [3]. These indicators are “Disease-Based Criteria vs BMI Level for Prioritization of crucial for evaluating long-term surgical efficacy and patient Metabolic Surgery [1].” Drawing on data from 723 can- benefit. Moreover, the absence of real-world follow-up data didates for metabolic surgery, the authors systematically restricts the study’s capacity to assess the durability and gen- compared the prognostic and prioritization value of BMI, eralizability of its findings. type 2 diabetes (T2D), and cardiovascular disease (CVD). Third, the scope and control of variables could be further Their findings present a compelling challenge to the current refined. In addition to standard measures like BMI, T2D, and BMI-centric surgical assessment paradigm. We commend CVD, the study omits important determinants http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Obesity Surgery Springer Journals

BMI Is Only the Beginning: Accounting for Comorbidity Burden and Patient Heterogeneity

Cheng, Yuan; Wei, Bin
Obesity Surgery , Volume 35 (8) – Aug 1, 2025
Download PDF
2 pages

Loading next page...
 
/lp/springer-journals/bmi-is-only-the-beginning-accounting-for-comorbidity-burden-and-a8FdJLFBJN

References (3)

Publisher
Springer Journals
Copyright
Copyright © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2025
ISSN
0960-8923
eISSN
1708-0428
DOI
10.1007/s11695-025-08039-5
Publisher site
See Article on Publisher Site

Abstract

Obesity Surgery https://doi.org/10.1007/s11695-025-08039-5 EDITORIAL BMI Is Only the Beginning: Accounting for Comorbidity Burden and Patient Heterogeneity 1 1 Yuan Cheng  · Bin Wei Received: 24 June 2025 / Revised: 25 June 2025 / Accepted: 30 June 2025 © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2025 Dear Editor, incorporate key postoperative endpoints such as T2D remis- sion, magnitude of weight loss, reduction in medication use, We read with great interest the study by Roser et al., titled or improvements in quality of life [3]. These indicators are “Disease-Based Criteria vs BMI Level for Prioritization of crucial for evaluating long-term surgical efficacy and patient Metabolic Surgery [1].” Drawing on data from 723 can- benefit. Moreover, the absence of real-world follow-up data didates for metabolic surgery, the authors systematically restricts the study’s capacity to assess the durability and gen- compared the prognostic and prioritization value of BMI, eralizability of its findings. type 2 diabetes (T2D), and cardiovascular disease (CVD). Third, the scope and control of variables could be further Their findings present a compelling challenge to the current refined. In addition to standard measures like BMI, T2D, and BMI-centric surgical assessment paradigm. We commend CVD, the study omits important determinants

Journal

Obesity Surgery – Springer Journals

Published: Aug 1, 2025

There are no references for this article.